Bone Therapeutics inks iPSC related research partnership 28-Sep-2021 By Jane Byrne A new deal sees Bone Therapeutics gain access to iPSC derived, genetically engineered MSCs.
Belgian cell therapy firm signs €16m loan with EIB for development of orthopedic treatments 06-Jul-2021 By Jane Byrne Cell therapy player, Bone Therapeutics, has secured up to €16m (US$18.9m) in a financing loan from the European Investment Bank (EIB) to accelerate ongoing clinical and commercial development of innovative orthopedic treatments.